Outlook Therapeutics
OTLK
OTLK
17 hedge funds and large institutions have $4.96M invested in Outlook Therapeutics in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.02% less ownership
Funds ownership: 0.12% → 0.1% (-0.02%)
20% less capital invested
Capital invested by funds: $6.16M → $4.96M (-$1.21M)
Holders
17
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$40.9K | |
| 2 | +$35.7K | |
| 3 | +$32K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$30.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$5.86K |